ArticleJournal of experimental & clinical cancer research : CR2019

Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade.

Linan Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.